Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.
Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...
Morning Overview on MSN
Why you should never pop a pimple in the face triangle
When it comes to facial skincare, there’s a zone that demands extra caution: the “triangle of death.” This area, extending ...
Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
A few things happen when you get a corticosteroid injection at the dermatologist’s office. “We inject it into active inflamed ...
Newspoint on MSN
Skin Care Tips: If you have a habit of washing your face frequently, then read this news to keep problems away from you..
Many of us think that washing your face frequently will keep your skin clean and blemish-free. But did you know that frequent ...
You may not give much thought to your armpits, apart from checking whether they need another swipe of deodorant. But this ...
WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback